The Role of MRI in Imaging Metal Implants


Hollis G. Potter, MD

Hollis G. Potter, MD

Chairman, Division of Magnetic Resonance Imaging
Attending Radiologist, Hospital for Special Surgery
Professor of Radiology, Weill College of Medicine of Cornell University

As the number of primary hip arthroplasties is expected to increase substantially over the next 15 years, the need for noninvasive, accurate diagnosis in the assessment of adverse conditions following arthroplasty placement is essential [1].  The recent recalls of metal on metal (MOM) total hip replacements, as well as some modular nonmetal on metal designs, combined with the British MHRA press release in 2012 and the 2011 FDA 522 Post Market Surveillance Call establishes a basis for the potential use of cross-sectional imaging in the evaluation of these patients. 

The Hospital for Special Surgery  (HSS) MRI Department’s previous interest in the evaluation of arthroplasty was founded in the detection of osteolysis, given that the condition was one of the more common problems encountered with the commonly-utilized metal on polyethylene (MOP) compounds. We have previously demonstrated that MRI was more sensitive than radiographs in detecting osteolysis, and further that it was the most accurate means by which to quantify and locate osteolysis following total hip arthroplasties, when compared to conventional radiographs or optimized CT evaluation [2, 3, 4].

Although the cellular basis of both osteolysis and local adverse tissue reaction is still not well established, we recognize that osteolysis is an inflammatory upregulation of osteoclasts and downregulation of osteoblasts, thereby leading to aseptic loosening [5]. 

In MOM constructs, there appear to be both cell-mediated and foreign body reactions resulting in a delayed type hypersensitivity reaction resulting in local tissue necrosis, termed by investigators from the United Kingdom as “pseudotumors”.  Foreign body reaction or metallic debris may be seen in the absence of tissue necrosis. This is often noted in patients with abnormal radiographic measurements, leading to increased loads upon the implant and metallic wear.

More recently, tribocorrosion due to a combination of corrosion from electrochemical reaction between slightly different metallic composites, and wear due to mechanical degradation due to offset geometry, has been seen around modular head-neck junctions, modular stems or at the trunnion. Given this latter reaction, we recognize that adverse tissue reactions may occur in all bearing constructs, and not just those composed of MOM designs. Thus, early detection of adverse tissue reactions is essential. The findings from the UK [6, 7] demonstrate the utility of imaging in diagnosing these conditions. 

Adverse tissue reactions can occur in both symptomatic and asymptomatic cohorts; Hart et al. noted that the prevalence of “pseudotumors” was not significantly different in painful versus asymptomatic well-functioning arthroplasties [7]. The finding of a high prevalence of adverse tissue reactions in asymptomatic MOM arthroplasties has also been noted by additional investigators [8, 9].

In our own recently published study of 73 hips in 68 patients with resurfacing arthroplasty, there was a similar volume of synovitis in symptomatic and asymptomatic cohorts [10]. Of note, in the patients who underwent revision, the mean volume of synovitis was higher in those patients who also had a documented adverse tissue reaction at revision. While previous groups have devised observational MR classification systems, our group has attempted to correlate MRI findings to both clinically and biologically relevant outcomes.

In a recently published study, we noted that the combination of several MR variables, most notably the presence of solid synovial deposits and maximum synovial thickness, were highly correlated to both the intensity of the ALVAL score, a histologic score obtained on tissue at the time of the revision, as well as the degree of intraoperative tissue damage present [11]. The sensitivity and specificity for MRI was higher than that which has been reported for metal ion levels [11]. Increasingly, metal ion levels have shown to be poorly predictive of the presence and extent of adverse tissue reaction [12].

While patients may have pain that is explained by physical examination or radiographic findings, an important group of patients have “unexplained pain”. In a further study correlating MR findings to wear analysis, our group noted that articular wear rates were lower in the unexplained pain group than in the control group, and that synovial thickness on MRI was statistically higher in the unexplained pain group and highly predictive of adverse histologic score at the time of revision [13].

We are continuing to study the effects of tribocorrosion as well as the effects of reactions around MOM implants. Our recently awarded R01 (NIH 1 R01 AR064840) research grant will provide us with a very effective means to longitudinally assess different types of implants. This grant will support an extraordinarily collaborative effort between HSS scientists looking at wear patterns using retrieval analysis in Dr. Timothy Wright’s lab, the arthroplasty service under the direction of Dr. Douglas Padgett, and the MRI lab under the co-direction of both myself and Dr. Matthew Koff.  The diagnosis of adverse tissue reactions is made dramatically easier by the advent of newer pulse sequences aimed at reducing susceptibility artifact associated with the metallic components of the arthroplasty. Our collaborations with General Electric Healthcare have been very efficacious in that regard, with the development of the new “MAVRIC” pulse sequence [14, 15]. 

Overall, the evaluation of adverse reactions around implants reflects a cooperative effort between the Departments of Radiology and Imaging, Biomechanics, Pathology and Laboratory Medicine, and the Arthroplasty Service. Additional collaborators, including Dr. Edward Purdue in the Osteolysis Research Laboratory, will provide insight into cellular mechanisms which produce these adverse reactions.

The unique multidisciplinary efforts of HSS scientists, clinician scientists and clinicians will set the stage for an important road to discovery in the biology of this process.

References

1. Kurtz S, Ong K, Lau E, Mowat F, Halpern M.  Projections of Primary and Revision Hip and Knee Arthroplasty in the United States from 2005 to 2030.  J Bone Joint Surg 2007; 89: 780-785. 

2. Potter HG, Nestor BJ, Sofka CM, Ho ST, PetersLE, Salvati EA. Magnetic resonance imaging after total hip arthroplasty: evaluation of periprosthetic soft tissue. J Bone Joint Surg Am 2004;86:1947–1954. 

3. Walde TA, Weiland DE, Leung SB, et al. Comparison of CT, MRI, and radiographs in assessing pelvic osteolysis: a cadaveric study. Clin Orthop Relat Res 2005; 437:138–144.

4. Weiland DE, Walde TA, Leung SB, et al. Magnetic resonance imaging in the evaluation of periprosthetic acetabular osteolysis: a cadaveric study. J Orthop Res 2005; 23:713–719.

5. Purdue PE, Koulouvaris P, Potter HG, Nestor BJ, Sculco TP. The cellular and molecular biology of periprosthetic osteolysis. Clin Orthop Rel Res 2007; 454:251-61.

6. Thomas MS, Wimhurst JA, Nolan JF, Toms AP.  Imaging metal-on-metal hip replacements: The Norwich experience.  HSS J 2013; 9(3):247-256.

7. Hart AJ, Satchithananda K, Liddle AD, Sabah SA, McRobbie D, Henckel J, Cobb JP, Skinner JA, Mitchell AW. Pseudotumors in association with well-functioning metal-on-metal hip prostheses: a case-control study using three-dimensional computed tomography and magnetic resonance imaging. J Bone Joint Surg Am. 2012:15;94(4):317-25.

8. Kwon YM, Jacobs JJ, Macdonald SJ, Potter HG, Fehring TK, Lombardi AV. Evidence-based understanding of management perils for metal-on-metal hip arthroplasty patients. J Arthroplasty. 2012;27 (8 Suppl):20-5.

9. Fehring TK, Odum S, Sproul R, Weathersbee J. High Frequency of Adverse Local Tissue Reactions in Asymptomatic Patients With Metal-on-Metal THA. Clin Orthop Relat Res. 2013, Epub ahead of print

10. Nawabi DH, Hayter CL, Su EP, Koff MF, Perino G, Gold SL, Koch KM, Potter HG.  Magnetic resonance imaging findings in symptomatic versus asymptomatic subjects following metal-on-metal hip resurfacing arthroplasty.  J Bone Joint Surg 2013; 95(10):895-902.

11. Nawabi DH, Gold SL, Lyman S, Fields K, Padgett DP, Potter HG. MRI predicts ALVAL and tissue damage in metal-on-metal hip arthroplasty.  Clin Orthop Relat Res 2013, epub ahead of print.

12. Hart AJ, Matthies A, Henckel J, Ilo K, Skinner J, Noble PC. Understanding why metal-on-metal hip arthroplasties fail: a comparison between patients with well-functioning and revised Birmingham hip resurfacing arthroplasties. AAOS exhibit selection. J Bone Joint Surg Am. 2012 Feb 15;94(4):e22.

13. Nawabi DH, Nassif NA, Do HT,  Stoner K, Elpers M, Su EP, Wright T, Potter HG, Padgett DE.  What causes unexplained pain in patients with metal-on metal hip devices? A retrieval, histologic, and imaging analysis.  Clin Orthop Relat Res 2013, in press. 

14. Hayter CL, Koff MF, Shah P, Koch KM, Miller TT, Potter HG.  MRI after arthroplasty:  comparison of MAVRIC and conventional Fast Spin Echo Techniques. AJR 2011;197(3):W405-11.

15. Hayter CL, Gold SL, Koff MF, Perino G, Nawabi DH, Miller TT, Potter HG. MRI findings in painful metal-on-metal hip arthroplasty. Am J Roentgenol. 2012;199(4):884-93.

^ Back to Top
Request an Appointment